Catalyst Wire Dossier Catalyst Wire Dossier

INCB009471

· Incyte Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INCB009471, covering 2018-03-26 to 2018-03-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety/Effectiveness of Oral Chemokine Coreceptor 5 (CCR5) Antagonist INCB009471 in R5-tropic HIV Infected Patients [Phase 2]

See pricing